Abstract

Three-dimensional ‎(‎3D) technique of restricting scrambling is changing the ways of drug design, labeling and ‎production in the area of ‎digital health. By combining digital and genetic techniques, Fused ‎Deposition Modeling (FDM) can manufacture ‎normalization systems. Consecutively, such a ‎method can allow for speedy improvements in the healthcare ‎systems, allowing the allocation ‎of medicines based on patient’s needs and requirements. So far, several 3D ‎based medicinal ‎goods have been marketed. These include the production of implants and several useful related ‎‎products for use in medical applications. Nevertheless, regulatory obstacles remain with ‎developing medicines. ‎This article reviews the latest FDM technology in medical and ‎pharmaceutical research, including a discussion of ‎the potential challenges in the field. ‎Emphasis has been paid on future developments needed for facilitating the ‎FDM integration ‎into dispensaries and clinics.‎

This work is licensed under a Creative Commons Attribution 4.0 License.